PRavastatin Or atorVastatin Evaluation and Infection Therapy (TIMI 22)

Disclosure Statement:  Dr. Cannon currently receives research grant support from Bristol-Myers Squibb, Merck and Sanofi-Synthelabo.  He serves as a consultant to AstraZeneca, Glaxo Smith Kline, Guilford Pharmaceuticals and Vertex